secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2023-04-14T23:59:59+00:00
Accession:  0001213900-23-029663
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avra Medical Robotics enters $3M investment agreement with Dr. Moll convertible into 7% of post-merger equity
--------------------------------------------------------------------------------

- Dr. Moll provides additional $1M (total $3M) interim financing for CardioVentures working capital.
- Upon merger close, Moll receives 7% of SSII on fully-diluted basis; Srivastava forfeits 2% of CardioVentures shares.
- If merger not consummated by April 14, 2023, Moll has put right to cash repayment at 7% annual return (12% if late).
- Merger would rename company to SS Innovations International, Inc. (SSII) and combine with CardioVentures.
- Financing priced at $100M pre-money valuation; anti-dilution adjustment if future capital raised below that.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390023029663/0001213900-23-029663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390023029663/ea176767-8k_avramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-029663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer